Comments
Loading...
Artelo Biosciences (ARTL) Forecast
NewsEarningsArtelo Biosciences (ARTL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestArtelo Biosciences (NASDAQ:ARTL) Stock Quotes, Forecast and News Summary
Artelo Biosciences Stock (NASDAQ: ARTL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Artelo Biosciences (ARTL) stock?
You can purchase shares of Artelo Biosciences (NASDAQ:ARTL) through any online brokerage.
Who are Artelo Biosciences (ARTL) competitors?
Other companies in Artelo Biosciences’s space includes: Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), Titan Pharma (NASDAQ:TTNP), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).
What is the forecast, or price target, for Artelo Biosciences (ARTL) stock?
Artelo Biosciences has a consensus price target of $19.25.
What is the current price for Artelo Biosciences (ARTL)?
The stock price for Artelo Biosciences (NASDAQ: ARTL) is $1.04 last updated December 18, 2024 at 11:34 AM EST.
Does Artelo Biosciences (ARTL) pay a dividend?
There are no upcoming dividends for Artelo Biosciences.
When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?
Artelo Biosciences’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Artelo Biosciences (ARTL) going to split?
There is no upcoming split for Artelo Biosciences.
What sector and industry does Artelo Biosciences (ARTL) operate in?
Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.